Cargando…
mRNA-Loaded Lipid Nanoparticles Targeting Dendritic Cells for Cancer Immunotherapy
Dendritic cells (DCs) are attractive antigen-presenting cells to be targeted for vaccinations. However, the systemic delivery of mRNA to DCs is hampered by technical challenges. We recently reported that it is possible to regulate the size of RNA-loaded lipid nanoparticles (LNPs) to over 200 nm with...
Autores principales: | Sasaki, Kosuke, Sato, Yusuke, Okuda, Kento, Iwakawa, Kazuki, Harashima, Hideyoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413374/ https://www.ncbi.nlm.nih.gov/pubmed/36015198 http://dx.doi.org/10.3390/pharmaceutics14081572 |
Ejemplares similares
-
The silencing of indoleamine 2,3-dioxygenase 1 (IDO1) in dendritic cells by siRNA-loaded lipid nanoparticles enhances cell-based cancer immunotherapy
por: Endo, Rikito, et al.
Publicado: (2019) -
mRNA-Loaded Lipid Nanoparticles Targeting Immune Cells in the Spleen for Use as Cancer Vaccines
por: Shimosakai, Ryoya, et al.
Publicado: (2022) -
Mixing lipids to manipulate the ionization status of lipid nanoparticles for specific tissue targeting
por: Shobaki, Nour, et al.
Publicado: (2018) -
Three-dimensional, symmetrically assembled microfluidic device for lipid nanoparticle production
por: Kimura, Niko, et al.
Publicado: (2021) -
Genetically engineered transfusable platelets using mRNA lipid nanoparticles
por: Leung, Jerry, et al.
Publicado: (2023)